• Episode 11: ASCO Annual Meeting 2024 Commentary: Prostate Cancer

  • 2024/06/06
  • 再生時間: 30 分
  • ポッドキャスト

Episode 11: ASCO Annual Meeting 2024 Commentary: Prostate Cancer

  • サマリー

  • Dr. Lalani and Dr. Wallis cover the utility of metformin, quality of life analyses, and optimizing treatment approaches for resistant prostate cancer, including the place for radioligand therapies.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers.

    Learn more about The View on GU: https://theviewongu.com

    This podcast has been made possible through financial support by Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Ipsen, Merck, Novartis, Pfizer and TerSera.

    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

Dr. Lalani and Dr. Wallis cover the utility of metformin, quality of life analyses, and optimizing treatment approaches for resistant prostate cancer, including the place for radioligand therapies.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers.

Learn more about The View on GU: https://theviewongu.com

This podcast has been made possible through financial support by Astellas, AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Ipsen, Merck, Novartis, Pfizer and TerSera.

Episode 11: ASCO Annual Meeting 2024 Commentary: Prostate Cancerに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。